Glytone Acne — Class III drug recall D-1285-2014
Terminated recall by Genesis Pharmaceutical, Inc., reported 2014-05-07, distributed nationwide. Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatme
| Recall number | D-1285-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Genesis Pharmaceutical, Inc., Henderson, NV, United States |
| Recall initiated | 2014-04-01 |
| Classified | 2014-04-29 |
| Reported by FDA | 2014-05-07 |
| Terminated | 2014-10-15 |
| Distributed | Nationwide (US) |
| Quantity | 461 bottles |
| Reason classes | specification failure |
| UPC / GTIN / UDI-DI | 00304760004132 |
| Expiration dates | 2016-01-14 |
Product
Glytone Acne, acne treatment facial cleanser, 2% Salicylic Acid, 200 mL/6.7 FL Oz Bottle, Distributed by Genesis Pharmaceuticals, Inc. a subsidiary of Pierre Fabre, Parsippany, NJ 07054, UPC 3 04760-00413-2
Reason for recall
Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1285-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.